<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht003090.v1" study_id="phs000209.v11" participant_set="3" date_created="Mon Feb 25 01:02:30 2013"><variable id="phv00175994.v1"><name>sidno</name><description>SHARE ID NUMBER</description><type>NUMERIC</type></variable><variable id="phv00175995.v1"><name>volvitk1</name><description>VOLUME</description><type>Numeric</type></variable><variable id="phv00175996.v1"><name>vitk1</name><description>PHYLLOQUINONE (nmol/L)</description><type>Numeric</type><unit>nmol/L</unit></variable><variable id="phv00175997.v1"><name>vitk1m</name><description>PHYLLOQUINONE: INDICATOR VALUE</description><type>Numeric</type><value code="0">Below Lower Limit of Detection of 0.1 nmol/L</value><value code="1">Quantity of sample non-sufficient for analysis</value></variable><variable id="phv00175998.v1"><name>dhvitk1</name><description>DIHYDROPHYLLOQUINONE (nmol/L)</description><type>Numeric</type><unit>nmol/L</unit></variable><variable id="phv00175999.v1"><name>dhvitk1m</name><description>DIHYDROPHYLLOQUINONE: INDICATOR VALUE</description><type>Numeric</type><value code="0">Below Lower Limit of Detection of 0.1 nmol/L</value></variable><variable id="phv00176000.v1"><name>cacfastp</name><description>CAC FAST PROGRESSOR INDICATOR</description><type>Numeric</type></variable><variable id="phv00176001.v1"><name>yearlyinc</name><description>YEARLY INCREASE IN CAC</description><type>Numeric</type></variable><variable id="phv00176002.v1"><name>rregweight</name><description>WEIGHT FROM ROBUST REGRESSION MODELS</description><type>Numeric</type><value code="0">0 weight (highest evidence for fast CAC progression)</value><value code="1">Small non zero weight (evidence for fast CAC progression)</value></variable><variable id="phv00176003.v1"><name>group3</name><description>GROUP 3 COHORT INDICATOR</description><type>Numeric</type><value code="0">No</value><value code="1">Yes</value></variable><variable id="phv00176004.v1"><name>warf1c</name><description>ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE</description><type>Numeric</type></variable><variable id="phv00176005.v1"><name>casecohdes</name><description>CASE-COHORT DESIGNATION</description><type>Numeric</type><value code="0">Cohort Only (not a case)</value><value code="1">Cohort AND a Case</value><value code="2">Case Only (not cohort)</value></variable><variable id="phv00176006.v1"><name>replace</name><description>SAMPLE REPLACEMENT</description><type>Numeric</type><value code="0">No</value><value code="1">Yes</value></variable></data_table>
